Cocrystal Pharma获得艾默里大学医学院的伦理委员会批准,开展CDI-988预防和治疗诺瓦克病毒的1B期人类挑战研究

美股速递
Dec 18

Cocrystal Pharma获得艾默里大学医学院的伦理委员会批准,开展CDI-988预防和治疗诺瓦克病毒的1B期人类挑战研究。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10